Analysts Estimate Report : What to Look Out for Cantel Medical (NYSE:CMD)

0
212

Earnings results for Cantel Medical (NYSE:CMD)

Cantel Medical Corp. is expected* to report earnings on 09/17/2020 before market open. The report will be for the fiscal Quarter ending Jul 2020. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.08. The reported EPS for the same quarter last year was $0.63.

Analyst Opinion on Cantel Medical (NYSE:CMD)

3 Wall Street analysts have issued ratings and price targets for Cantel Medical in the last 12 months. Their average twelve-month price target is $60.33, predicting that the stock has a possible upside of 22.88%. The high price target for CMD is $65.00 and the low price target for CMD is $51.00. There are currently 1 sell rating and 2 buy ratings for the stock, resulting in a consensus rating of “Hold.”

Cantel Medical has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating. According to analysts’ consensus price target of $60.33, Cantel Medical has a forecasted upside of 22.9% from its current price of $49.10. Cantel Medical has only been the subject of 1 research reports in the past 90 days.

Dividend Strength: Cantel Medical (NYSE:CMD)

Cantel Medical has a dividend yield of 0.42%, which is in the bottom 25% of all stocks that pay dividends. Cantel Medical does not have a long track record of dividend growth. The dividend payout ratio of Cantel Medical is 8.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cantel Medical will have a dividend payout ratio of 11.41% next year. This indicates that Cantel Medical will be able to sustain or increase its dividend.

Insiders buying/selling: Cantel Medical (NYSE:CMD)

In the past three months, Cantel Medical insiders have not sold or bought any company stock. Only 10.90% of the stock of Cantel Medical is held by insiders. 97.88% of the stock of Cantel Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Cantel Medical (NYSE:CMD

Earnings for Cantel Medical are expected to grow by 22.67% in the coming year, from $1.50 to $1.84 per share. The P/E ratio of Cantel Medical is 73.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.06. The P/E ratio of Cantel Medical is 73.28, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.81. Cantel Medical has a PEG Ratio of 8.71. PEG Ratios above 1 indicate that a company could be overvalued. Cantel Medical has a P/B Ratio of 3.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here